PRILOG POTVRDI O AKREDITACIJI br - Klinički zavod za kemiju

klinkemija.kbcsm.hr

PRILOG POTVRDI O AKREDITACIJI br - Klinički zavod za kemiju

PRILOG POTVRDI O AKREDITACIJI br: 7132<br />

Annex to Accreditation Certificate Number:<br />

Klasa/Ref. No.: 383-02/12-35/007<br />

Urbroj/Id. No.: 569-02/2-12-41<br />

Datum izdanja priloga /Annex Issued on: 2012-12-28<br />

Norma: HRN EN ISO 15189:2008<br />

Standard: (ISO 15189:2007; EN ISO 15189:2007)<br />

Akreditacija istječe: 2017-12-27<br />

Accreditation expiry:<br />

Prva akreditacija: 2007-12-28<br />

Initial accreditation:<br />

Akreditirani laboratorij<br />

Accredited laboratory<br />

KLINIČKI BOLNIČKI CENTAR SESTRE MILOSRDNICE<br />

KLINIČKI ZAVOD ZA KEMIJU<br />

Klinička jedinica za prijem bolesnika i distribuciju uzoraka<br />

Klinička jedinica za medicinsku biokemiju s analitičkom toksikologijom<br />

Klinička jedinica za laboratorijsku hematologiju i koagulaciju<br />

Klinička jedinica za specijalnu medicinsku biokemiju<br />

Klinička jedinica za molekularnu dijagnostiku<br />

Vinogradska 29, HR-10000 Zagreb<br />

Područje akreditacije:<br />

Scope of accreditation:<br />

Medicinska biokemija - ispitivanja u području kliničke kemije,<br />

laboratorijske hematologije i koagulacije, laboratorijske imunologije, toksikologije<br />

i molekularne dijagnostike<br />

Medical Biochemistry – Testing in the field of Clinical Chemistry, Laboratory<br />

Hematology and Coagulation, Laboratory Immunology, Toxicology and<br />

Molecular Diagnostics<br />

Važeće izdanje Priloga dostupno je na web adresi: www.akreditacija.hr /<br />

Valid issue of the Annex is available at the web address: www.akreditacija.hr<br />

Ravnateljica:<br />

Director General:<br />

mr. sc. Biserka Bajzek Brezak, dipl. ing.<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 1 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

PODRUČJE AKREDITACIJE / SCOPE OF ACCREDITATION<br />

Klinička jedinica za medicinsku biokemiju s analitičkom toksikologijom<br />

Klinička kemija/Clinical Chemistry<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

Alkalna fosfataza (ALP)<br />

Alkaline phosphatase (ALP)<br />

MP-5.5-031-1/1<br />

Fotometrija<br />

Photometry<br />

2.<br />

Gama-glutamiltransferaza<br />

(GGT)<br />

Gamma glutamyltransferase<br />

MP-5.5-031-2/1<br />

3.<br />

4.<br />

Aspartat-aminotransferaza<br />

(AST)<br />

Aspartate-aminotransferase<br />

Alanin-aminotransferaza (ALT)<br />

Alanine-aminotransferase<br />

(ALT)<br />

MP-5.5-031-3/1<br />

MP-5.5-031-4/1<br />

Kinetička UV metoda<br />

Kinetic UV method<br />

Serum, plazma<br />

Serum, plasma<br />

5.<br />

Kreatin-kinaza (CK)<br />

Creatine-kinase (CK)<br />

MP-5.5-031-5/1<br />

6.<br />

Kreatin kinaza, MB izoenzim<br />

(CK-MB)<br />

Creatinine kinase, MB<br />

isoenzyme (CK-MB)<br />

MP-5.5-031-6/1<br />

Enzimatski imunoinhibicijski<br />

test<br />

Enzymatic immunoinhibition<br />

test<br />

7.<br />

8.<br />

Laktat-dehidrogenaza (LD)<br />

Lactate-dehidrogenase (LD)<br />

Amilaza<br />

Amylase<br />

MP-5.5-031-7/1<br />

MP-5.5-031-8/1<br />

Kinetička UV metoda<br />

Kinetic UV method<br />

Serum, plazma,<br />

punktati<br />

Serum, plasma<br />

aspirated fluid<br />

9.<br />

Amilaza<br />

Amylase<br />

MP-5.5-031-9/1<br />

Mokraća, dren<br />

Urine, effluent,<br />

aspirated fluid<br />

10.<br />

Lipaza<br />

Lipase<br />

MP-5.5-031-10/1<br />

11.<br />

12.<br />

Kolinesteraza<br />

Cholinesterase<br />

Angiotenzin-konvertirajući<br />

enzim (ACE)<br />

Angiotensin converting enzyme<br />

MP-5.5-031-14/1<br />

MP-5.5-031-15/1<br />

Refleksna fotometrija<br />

Reflectance photometry<br />

Fotometrija<br />

Photometry<br />

Serum, plazma<br />

Serum, plasma<br />

13.<br />

Kalij<br />

Potassium<br />

MP-5.5-031-16/1<br />

Indirektna potenciometrija<br />

Indirect potentiometry<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 2 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

14.<br />

15.<br />

Natrij<br />

Sodium<br />

Kloridi<br />

Chloride<br />

MP-5.5-031-17/1<br />

MP-5.5-031-18/1<br />

Indirektna potenciometrija<br />

Indirect potentiometry<br />

16.<br />

Kalcij<br />

Calcium<br />

MP-5.5-031-19/1<br />

Serum, plazma<br />

Serum, plasma<br />

17.<br />

Anorganski fosfati<br />

Inorganic phosphorus<br />

MP-5.5-031-20/1<br />

Fotometrija<br />

Photometry<br />

18.<br />

Magnezij<br />

Magnesium<br />

MP-5.5-031-21/1<br />

19.<br />

20.<br />

Kalij<br />

Potassium<br />

Natrij<br />

Sodium<br />

MP-5.5-031-22/1<br />

MP-5.5-031-23/1<br />

Indirektna potenciometrija<br />

Indirect potentiometry<br />

Porcija mokraće,<br />

24-satna mokraća<br />

Urine<br />

21.<br />

22.<br />

23.<br />

Kloridi<br />

Chloride<br />

Kalcij<br />

Calcium<br />

Anorganski fosfati<br />

Inorganic phosphorus<br />

MP-5.5-031-24/1<br />

MP-5.5-031-25/1<br />

MP-5.5-031-26/1<br />

Fotometrija<br />

Photometry<br />

Porcija mokraće,<br />

24-satna mokraća<br />

Urine, random<br />

sample and 24h<br />

24.<br />

Magnezij<br />

Magnesium<br />

MP-5.5-031-27/1<br />

25.<br />

Trigliceridi<br />

Triglyceride<br />

MP-5.5-031-28/1<br />

Serum, plazma,<br />

punktati<br />

Serum, plasma,<br />

aspirated fluid<br />

26.<br />

27.<br />

Kolesterol<br />

Cholesterol<br />

Kolesterol, HDL<br />

Cholesterol, HDL<br />

MP-5.5-031-29/1<br />

MP-5.5-031-30/1<br />

Enzimatska fotometrijska<br />

metoda<br />

Enzymatic photometric<br />

method<br />

Serum, plazma<br />

Serum, plasma<br />

28.<br />

Kolesterol, LDL<br />

Cholesterol, LDL<br />

MP-5.5-031-31/1<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 3 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

29.<br />

Kolesterol, LDL<br />

Cholesterol, LDL<br />

MP-5.5-031-32/1<br />

Računski parametar<br />

Računski parametar<br />

30.<br />

31.<br />

Bilirubin, ukupni<br />

Bilirubin, total<br />

Bilirubin, konjugirani<br />

Bilirubin, direct<br />

MP-5.5-031-33/1<br />

MP-5.5-031-34/1<br />

Fotometrija<br />

Photometry<br />

Serum, plazma<br />

Serum, plasma<br />

32.<br />

Bilirubin, nekonjugirani<br />

Bilirubin, indirect<br />

MP-5.5-031-35/1<br />

Računski parametar<br />

Calculated parameter<br />

33.<br />

34.<br />

Ureja<br />

Urea<br />

Ureja<br />

Urea<br />

MP-5.5-031-36/1<br />

MP-5.5-031-37/1<br />

Kinetička UV metoda<br />

kinetic UV metthod<br />

Porcija mokraće,<br />

24-satna mokraća<br />

Urine, random<br />

35.<br />

36.<br />

37.<br />

38.<br />

Urat<br />

Uric acid<br />

Urat<br />

Uric acid<br />

Kreatinin<br />

Creatinine<br />

Kreatinin<br />

Creatinine<br />

MP-5.5-031-38/1<br />

MP-5.5-031-39/1<br />

MP-5.5-031-40/1<br />

MP-5.5-031-41/1<br />

Enzimatska fotometrijska<br />

metoda<br />

Enzymatic photometric<br />

method<br />

Kinetička nekompenzirana<br />

metoda<br />

Kinetic method<br />

Kinetička metoda<br />

Kinetic method<br />

Serum, plazma<br />

Serum, plasma<br />

Porcija mokraće,<br />

24-satna mokraća<br />

Urine, random<br />

Serum, plazma<br />

Serum, plasma<br />

Porcija mokraće,<br />

24-satna mokraća<br />

Urine, random<br />

39.<br />

Klirens kreatinina<br />

Creatinine clereance<br />

MP-5.5-031-42/1<br />

Računski parametar<br />

Calculated parameter<br />

24-satna mokraća i<br />

serum, plazma<br />

24h urine and<br />

serum, plasma<br />

40.<br />

41.<br />

Glukoza<br />

Glucose<br />

Glukoza<br />

Glucose<br />

MP-5.5-031-43/1<br />

MP-5.5-031-44/1<br />

Enzimatska fotometrijska<br />

metoda<br />

Enzymatic photometric<br />

method<br />

Serum, plazma,<br />

punktati<br />

Serum, plasma,<br />

aspirated fluid<br />

Mokraća<br />

Urine<br />

42.<br />

Laktat<br />

Lactate<br />

MP-5.5-031-46/1<br />

Enzimatska fotometrijska<br />

metoda<br />

Enzymatic photometric<br />

method<br />

Plazma, likvor<br />

Plasma, CSF<br />

43.<br />

Proteini, ukupni<br />

Total protein<br />

MP-5.5-031-48/1<br />

Fotometrija<br />

Photometry<br />

Serum, plazma,<br />

punktati<br />

Serum, plasma,<br />

aspirated fluid<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 4 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

44.<br />

45.<br />

Proteini, ukupni<br />

Total protein<br />

Albumin<br />

Albumin<br />

MP-5.5-031-49/1<br />

MP-5.5-031-50/1<br />

Fotometrija<br />

Photometry<br />

Mokraća, likvor<br />

Urine, CSF<br />

Serum, plazma,<br />

punktati<br />

Serum, plasma,<br />

46.<br />

Reumatoidni faktor (RF)<br />

Rheumatoid factor (RF)<br />

MP-5.5-031-51/1<br />

Serum, plazma<br />

Serum, plasma<br />

47.<br />

Anti-streptolizin O (ASO)<br />

Anti-streptolysin O (ASO)<br />

MP-5.5-031-52/1<br />

Imunoturbidimetrija<br />

Immunoturbidimetry<br />

Serum<br />

Serum<br />

48.<br />

C-reaktivni protein (CRP)<br />

C-reactive protein (CRP)<br />

MP-5.5-031-53/1<br />

49.<br />

50.<br />

Prokalcitonin<br />

Procalcitonin<br />

Troponin T<br />

Troponin T<br />

MP-5.5-031-54/1<br />

MP-5.5-031-55/1<br />

Elektrokemiluminiscentna<br />

imunoanaliza<br />

Electrochemiluminescece<br />

immunoassay<br />

51.<br />

52.<br />

Željezo<br />

Iron<br />

UIBC<br />

Unsaturated iron binding<br />

capacity (UIBC)<br />

MP-5.5-031-64/1<br />

MP-5.5-031-65/1<br />

Fotometrija<br />

Photometry<br />

Serum, plazma<br />

Serum, plasma<br />

53.<br />

54.<br />

TIBC<br />

Total iron binding capacity<br />

Fe-saturacija<br />

Fe-saturation<br />

MP-5.5-031-66/1<br />

MP-5.5-031-67/1<br />

Računski parametar<br />

Calculated parameter<br />

55.<br />

56.<br />

57.<br />

pH<br />

pH<br />

pCO2 (parcijalni tlak ugljičnog<br />

dioksida)<br />

pCO2 (Carbon dioxide partial<br />

pressure)<br />

pO2 (parcijalni tlak kisika)<br />

pO2 (oxygen partial pressure)<br />

MP-5.5-032-1/1<br />

MP-5.5-032-2/1<br />

MP-5.5-032-3/1<br />

Potenciometrija<br />

Potentiometry<br />

Amperometrija<br />

Amperometry<br />

Arterijska krv,<br />

kapilarna krv,<br />

venska plazma<br />

Artery/capillary<br />

blood, plasma<br />

58.<br />

Bikarbonati<br />

Bicarbonate<br />

MP-5.5-032-4/1<br />

Računski parametar<br />

Calculated parameter<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 5 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

59.<br />

Ukupni CO2 (tCO2)<br />

Total carbon dioxide (tCO2)<br />

MP-5.5-032-5/1<br />

60.<br />

BE (suvišak baze)<br />

BE (base excess)<br />

MP-5.5-032-6/1<br />

Računski parametar<br />

Calculated parameter<br />

Arterijska krv,<br />

kapilarna krv,<br />

venska plazma<br />

Artery/capillary<br />

blood, plasma<br />

61.<br />

Saturacija kisika<br />

Oxygen saturation<br />

MP-5.5-032-7/1<br />

62.<br />

Kalcij, ionizirani<br />

Calcium, ionized<br />

MP-5.5-032-8/1<br />

Potenciometrija<br />

Potentiometry<br />

Kapilarna krv<br />

Capillary blood<br />

63.<br />

64.<br />

Karboksihemoglobin<br />

Carboxyhemoglobin<br />

Methemoglobin<br />

Methemoglobin<br />

MP-5.5-032-9/1<br />

MP-5.5-032-10/1<br />

Spektrofotometrija<br />

Spectrophotometry<br />

Puna krv<br />

Whole blood<br />

65.<br />

66.<br />

Eritrociti u likvoru<br />

Erithrocytes in CSF<br />

Stanice u likvoru (sve stanice<br />

osim eritrocita)<br />

Cells in CSF (all but<br />

erythrocytes)<br />

MP-5.5-032-11/1<br />

MP-5.5-032-12/1<br />

Mikroskopsko brojanje<br />

stanica u hemocitometru<br />

Microscopic count in<br />

haemocytometer<br />

Likvor<br />

CSF<br />

67.<br />

Vrsta stanica u likvoru<br />

Type of cells in CSF<br />

MP-5.5-032-13/1<br />

Mikroskopski pregled<br />

Microscopic examination<br />

68.<br />

Dokazivanje pigmenata<br />

(bilirubin, oksihemoglobin,<br />

methemoglobin)<br />

MP-5.5-032-14/1<br />

Spektrofotometrija<br />

Spectrophotometry<br />

69.<br />

70.<br />

Relativna volumna masa<br />

Specific Gravity/Density<br />

pH<br />

pH<br />

MP-5.5-033-1/1<br />

MP-5.5-033-2/1<br />

Refleksna fotometrija<br />

Reflectance photometry<br />

Mokraća, punktati<br />

Urine, aspirated<br />

fluid<br />

71.<br />

72.<br />

Vizualni pregled mokraće<br />

Visual inspection of urine<br />

Proteini (test traka)<br />

Protein (test strip)<br />

MP-5.5-033-3/1<br />

MP-5.5-033-5/1<br />

Vizualna procjena<br />

Visual estimation<br />

Refleksna fotometrija<br />

Reflectance photometry<br />

Mokraća<br />

Urine<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 6 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

73.<br />

Glukoza (test traka)<br />

Glucose (test strip)<br />

MP-5.5-033-6/1<br />

74.<br />

Ketoni (test traka)<br />

Ketones (test strip)<br />

MP-5.5-033-7/1<br />

75.<br />

Urobilinogen (test traka)<br />

Urobilinogen (test strip)<br />

MP-5.5-033-8/1<br />

76.<br />

77.<br />

Bilirubin (test traka)<br />

Bilirubin (test strip)<br />

Nitriti (test traka)<br />

Nitrite (test strip)<br />

MP-5.5-033-9/1<br />

MP-5.5-033-10/1<br />

Refleksna fotometrija<br />

Reflectance photometry<br />

Mokraća<br />

Urine<br />

78.<br />

Eritrociti (test traka)<br />

Blood (test strip)<br />

MP-5.5-033-11/1<br />

79.<br />

Leukociti (test traka)<br />

Leucocytes (test strip)<br />

MP-5.5-033-12/1<br />

80.<br />

Pregled mokraćnog sedimenta<br />

The examination of the urinary<br />

sediment<br />

MP-5.5-033-13/1<br />

Mikroskopski pregled<br />

Microscopic examination<br />

81.<br />

Osmolalnost<br />

Osmolality<br />

MP-5.5-033-16/1<br />

Krioskopska osmometrija<br />

Cryoscopic osmometry<br />

Serum, mokraća<br />

Serum, urine<br />

82.<br />

Okultno krvarenje<br />

Fecal occult blood<br />

MP-5.5-033-15/1<br />

Gvajakov test<br />

Guaiac test<br />

stolica<br />

feces<br />

83.<br />

Porfirini (ukupni)<br />

Porphyins (total)<br />

MP-5.5-033-22/1<br />

Spektrofotometrija<br />

Spectrophotometry<br />

24-satna mokraća<br />

24h urine<br />

Toksikologija / Toxicology<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

Litij<br />

Lithium<br />

MP-5.5-031-56/1<br />

Fotometrija<br />

Photometry<br />

Serum, plazma<br />

Serum, plasma<br />

2.<br />

Ciklosporin<br />

Cyclosporine<br />

MP-5.5-031-57/1<br />

Imunofluorescentna<br />

polarizacija (FPIA)<br />

Fluorescence polarization<br />

immunoassay<br />

Puna krv<br />

Whole blood<br />

3.<br />

Digoksin<br />

Digoxin<br />

MP-5.5-031-58/1<br />

Enzim-imunoanaliza na<br />

mikročesticama MEIA<br />

Microparticle enzyme<br />

immunoassay<br />

Serum, plazma<br />

Serum, plasma<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 7 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

4.<br />

Fenobarbiton<br />

Phenobarbiton<br />

MP-5.5-031-59/1<br />

5.<br />

6.<br />

Karbamazepin<br />

Carbamazepine<br />

Valproična kiselina<br />

Valproic acid<br />

MP-5.5-031-60/1<br />

MP-5.5-031-61/1<br />

Imunofluorescentna<br />

polarizacija (FPIA)<br />

Fluorescence polarization<br />

immunoassay<br />

Serum, plazma<br />

Serum, plasma<br />

7.<br />

Teofilin<br />

Theophylline<br />

MP-5.5-031-62/1<br />

8.<br />

Etanol<br />

Ethanol<br />

MP-5.5-031-63/1<br />

Fotometrija<br />

Photometry<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 8 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

Klinička jedinica za laboratorijsku hematologiju i koagulaciju<br />

Laboratorijska hematologija/Laboratory Haematology<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

Kompletna krvna slika<br />

Haematology parameters on<br />

automated analyzer with<br />

differential blood<br />

count<br />

MP-5.5-041-1/1<br />

MP-5.5-041-2/1<br />

MP-5.5-041-3/1<br />

MP-5.5-041-4/1<br />

MP-5.5-041-5/1<br />

MP-5.5-041-6/1<br />

MP-5.5-041-7/1<br />

MP-5.5-041-8/1<br />

MP-5.5-041-12/1<br />

MP-5.5-041-13/1<br />

MP-5.5-041-14/1<br />

MP-5.5-041-15/1<br />

MP-5.5-041-16/1<br />

MP-5.5-041-17/1<br />

MP-5.5-041-18/1<br />

MP-5.5-041-19/1<br />

MP-5.5-041-20/1<br />

MP-5.5-041-21/1<br />

MP-5.5-041-22/1<br />

MP-5.5-041-23/1<br />

MP-5.5-041-25/1<br />

MP-5.5-041-26/1<br />

MP-5.5-041-32/1<br />

MP-5.5-041-33/1<br />

MP-5.5-041-34/1<br />

MP-5.5-041-35/1<br />

MP-5.5-041-36/1<br />

MP-5.5-041-37/1<br />

MP-5.5-041-38/1<br />

MP-5.5-041-39/1<br />

MP-5.5-041-40/1<br />

MP-5.5-041-41/1<br />

MP-5.5-041-42/1<br />

Optika i impedancija<br />

Optical count & impedantion<br />

Impedancija<br />

Impedantion<br />

Fotometrija/<br />

Photometry<br />

Optičko brojanje stanica<br />

Optical count cells<br />

Protočna citometrija<br />

Flow citometry<br />

VCS (volumetrija,<br />

provodljivost, raspšenje)<br />

VCS (viscosity, conductivity<br />

& scattering)<br />

Računski parametri/<br />

Calculated parameters<br />

Puna krv<br />

Whole blood<br />

2.<br />

Retikulociti (/10^3 Erc)<br />

Reticulocytes<br />

MP-5.5-041-9/1<br />

Impedancija<br />

Impedantion<br />

3.<br />

4.<br />

Retikulociti (x10^9/L)<br />

Reticulocytes – flow citomertry<br />

Indeks zrelosti retikulocita<br />

(IRF)<br />

Immature reticulocytes fraction<br />

MP-5.5-041-10/1<br />

MP-5.5-041-11/1<br />

Protočna citometrija<br />

Flow citometry<br />

5.<br />

DKS svjetlosna mikroskopija<br />

Leukocyte differentialperipheral<br />

blood smear<br />

MP-5.5-041-24/1<br />

Mikroskopski pregled<br />

Microscopic examination<br />

6.<br />

Krvne stanice u ascitesu<br />

Blood cells in ascites<br />

MP-5.5-041-27/1<br />

Optičko brojanje stanica<br />

Optical count cells<br />

Ascites<br />

Ascites<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 9 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

7.<br />

Krvne stanice u dijalizatu /<br />

punktatu<br />

Blood cells in<br />

dialysed/punctured specimen<br />

MP-5.5-041-28/1<br />

Optičko brojanje stanica<br />

Optical count cells<br />

Punktat<br />

Aspirated fluids<br />

8.<br />

Sedimentacija eritrocita –<br />

modifikacija metode po<br />

Westergrenu – ručna<br />

Erytrocytes sedimentation rate<br />

– modified Westergren method<br />

–manual<br />

MP-5.5-041-29/1<br />

Makroskopsko očitavanje<br />

stupca plazme<br />

Westergren method<br />

(macroscopic examine of<br />

erytrocytes sedimentation<br />

rate)<br />

9.<br />

Sedimentacija eritrocita BD –<br />

modificirana metoda po<br />

Westergrenu (automatska)<br />

Erytrocytes sedimentation rate<br />

– modified Westergren method<br />

(automated)<br />

MP-5.5-041-30/1<br />

Modificirana metoda po<br />

Westergrenu (automatska)<br />

Modificirana metoda po<br />

Westergrenu (automatska)<br />

Puna krv<br />

Whole blood<br />

10.<br />

Osmotska rezistencija eritrocita<br />

Osmotic fragility test<br />

MP-5.5-041-31/1<br />

Fotometrija<br />

Photometry<br />

Laboratorijska koagulacija/Laboratory Coagulation<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

Fibrinogen<br />

Fibrinogen<br />

MP-5.5-042-1/1<br />

2.<br />

3.<br />

4.<br />

5.<br />

6.<br />

Protrombinsko vrijeme (PV) -<br />

% aktivnosti<br />

Prothrombin time (PT) - %<br />

Protrombinsko vrijeme INR<br />

(PV INR)<br />

Prothrombin time INR (PT INR)<br />

Protrombinsko vrijeme INR<br />

(PV INR) – Coaguchek XS<br />

System<br />

Aktivirano parcijalno<br />

tromboplastinsko vrijeme<br />

(APTV) – sekunde<br />

Activated partial<br />

thromboplastin time (APTT) –<br />

seconds<br />

Aktivirano parcijalno<br />

tromboplastinsko vrijeme<br />

(APTV) – omjer<br />

Activated partial<br />

thromboplastin time (APTT) –<br />

MP-5.5-042-2/1<br />

MP-5.5-042-3/1<br />

MP-5.5-042-5/1<br />

MP-5.5-042-6/1<br />

MP-5.5-042-7/1<br />

Koagulometrija<br />

Coagulometry<br />

Refleksna fotometrija<br />

Reflectance photometry<br />

Koagulometrija<br />

Coagulometry<br />

Plazma<br />

Plasma<br />

Puna kapilarna krv<br />

Whole capilary<br />

blood<br />

Plazma<br />

Plasma<br />

7.<br />

Trombinsko vrijeme (TV)<br />

Thrombin time (TT)<br />

MP-5.5-042-8/1<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 10 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

8.<br />

D-dimeri<br />

D-dimers<br />

MP-5.5-042-11/1<br />

Imunoturbidimetrija<br />

Immunoturbidimetry<br />

9.<br />

Antitrombin (AT) - %<br />

aktivnosti<br />

Antithrombin (AT) - % activity<br />

MP-5.5-042-13/1<br />

Kromogena metoda<br />

Chromogenic assay<br />

10.<br />

Protein C (PC) - % aktivnosti<br />

Protein C (PC) - % activity<br />

MP-5.5-042-14/1<br />

11.<br />

Protein S (PS) - % aktivnosti<br />

Protein S (PS) - % activity<br />

MP-5.5-042-15/1<br />

12.<br />

Put proteina C (Put PC)<br />

Protein C pathway (PC<br />

pathway)<br />

MP-5.5-042-16/1<br />

13.<br />

Rezistencija na aktivirani<br />

protein C (APC rezistencija,<br />

APCR)<br />

MP-5.5-042-17/1<br />

14.<br />

Faktor II (FII) - % aktivnosti<br />

Factor II (FII) - % activity<br />

MP-5.5-042-18/1<br />

Koagulometrija<br />

Coagulometry<br />

15.<br />

Faktor V (FV) - % aktivnosti<br />

Factor V (FV) - % activity<br />

MP-5.5-042-19/1<br />

16.<br />

Faktor VII (FVII) - % aktivnosti<br />

Factor VII (FVII) - % activity<br />

MP-5.5-042-20/1<br />

Plazma<br />

Plasma<br />

17.<br />

Faktor VIII (FVIII) - %<br />

aktivnosti<br />

Factor VIII (FVIII) - % activity<br />

MP-5.5-042-21/1<br />

18.<br />

Faktor IX (FIX) - % aktivnosti<br />

Factor IX (FIX) - % activity<br />

MP-5.5-042-22/1<br />

19.<br />

Faktor X (FX) - % aktivnosti<br />

Factor X (FX) - % activity<br />

MP-5.5-042-23/1<br />

20.<br />

Faktor XI (FXI) - % aktivnosti<br />

Factor XI (FXI) - % activity<br />

MP-5.5-042-24/1<br />

Koagulometrija<br />

Coagulometry<br />

21.<br />

Faktor XII (FXII) - % aktivnosti<br />

Factor XII (FXII) - % activity<br />

MP-5.5-042-25/1<br />

22.<br />

Faktor XIII (FXIII) - %<br />

aktivnosti<br />

Factor XIII (FXIII) - % activity<br />

MP-5.5-042-26/1<br />

Kromogena metoda<br />

Chromogenic assay<br />

23.<br />

von Willebrandov faktor (vWF<br />

Ri:Co) - % aktivnosti<br />

Von Willebrand Factor (vWF<br />

MP-5.5-042-27/1<br />

Turbidimetrija<br />

Tubidimetry<br />

24.<br />

Lupus antikoagulant (LAC) –<br />

omjer<br />

Lupus anticoagulant (LAC) –<br />

MP-5.5-042-28/1<br />

Koagulometrija<br />

Coagulometry<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 11 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

25.<br />

Inhibitor faktora VIII<br />

Factor VIII inhibitor<br />

MP-5.5-042-32/1<br />

Koagulometrija<br />

Coagulometry<br />

26.<br />

Plazminogen - % aktivnosti<br />

Plasminogen - % activity<br />

MP-5.5-042-45/1<br />

Kromogena metoda<br />

Chromogenic assay<br />

Plazma<br />

Plasma<br />

27.<br />

APTV(s) test miješanja uz LAC<br />

APTT(s) mixing test for LAC<br />

MP-5.5-042-47/1<br />

Koagulometrija<br />

Coagulometry<br />

28.<br />

Heparin anti-Xa aktivnost<br />

Heparin anti-Xa activity<br />

MP-5.5-042-48/1<br />

Kromogena metoda<br />

Chromogenic assay<br />

Klinička jedinica za specijalnu medicinsku biokemiju<br />

Laboratorijska imunologija/Laboratory Imunology<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

Antitijela na humanu<br />

transglutaminazu IgA (tTG-<br />

IgA)<br />

MP-5.5-051-7/1<br />

2.<br />

3.<br />

Antitijela na cikličke<br />

citrulinirane peptide (anti-CCP)<br />

Anti-cyclic citrullinated<br />

Antikardiolipinska antitijela<br />

IgG<br />

Anti-cardiolipin IgG antibodies<br />

MP-5.5-051-8/1<br />

MP-5.5-051-9/1<br />

Enzimimuno analiza<br />

(ELISA)<br />

Enzyme-linked<br />

immunosorbent assay<br />

4.<br />

Antikardiolipinska antitijela<br />

IgM<br />

Anti-cardiolipin IgM antibodies<br />

MP-5.5-051-10/1<br />

5.<br />

6.<br />

7.<br />

ANCA screening<br />

Antibodies against cytoplasm of<br />

granulocytes (ANCA)<br />

Antitijela na proteinazu 3 (Pr-3)<br />

Anti-proteinase 3 (Anti-PR3)<br />

antibodies<br />

Antitijela na mijeloperoksidazu<br />

(MPO)<br />

Anti-myeloperoxidase (Anti-<br />

MP-5.5-051-13/1<br />

MP-5.5-051-14/1<br />

MP-5.5-051-15/1<br />

Indirektna<br />

imunofluorescencija<br />

Indirect immunofluorescence<br />

Enzimimuno analiza<br />

(ELISA)<br />

Enzyme-linked<br />

immunosorbent assay<br />

Serum, plazma<br />

Serum, plasma<br />

8.<br />

Antitijela na dvostruku<br />

uzvojnicu DNA (dsDNA)<br />

Autoantibodies to double-<br />

MP-5.5-051-16/1<br />

9.<br />

10.<br />

Antimitohondrijalna antitijela<br />

(AMA)<br />

Antimitochondrial antibodies<br />

Antitijela na glatku muskulaturu<br />

(AGLM)<br />

Antibodies against smooth<br />

MP-5.5-051-17/1<br />

MP-5.5-051-18/1<br />

Indirektna<br />

imunofluorescencija<br />

Indirect immunofluorescence<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 12 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

11.<br />

Antitijela na mikrosome jetre i<br />

bubrega (LKM)<br />

Antiobodies against liver-kidney<br />

microsomes (LKM)<br />

MP-5.5-051-19/1<br />

Indirektna<br />

imunofluorescencija<br />

Indirect immunofluorescence<br />

12.<br />

13.<br />

14.<br />

Antitijela na mikrosome jetre i<br />

bubrega usmjerena na LKM-1<br />

antigen<br />

Antimitohondrijalna antitijela<br />

(AMA) na M2 i 3E BPO<br />

antigen<br />

Antinuklearna antitijela (ANA)<br />

Antinuclear antibodies (ANA)<br />

MP-5.5-051-20/1<br />

MP-5.5-051-23/1<br />

MP-5.5-051-24/1<br />

Imunoblot<br />

Immunoblot<br />

Indirektna<br />

imunofluorescencija<br />

Indirect immunofluorescence<br />

Serum, plazma<br />

Serum, plasma<br />

15.<br />

Antitijela na ekstraktibilne<br />

nuklearne antigene (ENA),<br />

ELISA<br />

MP-5.5-051-25/1<br />

Enzimimuno analiza<br />

(ELISA)<br />

Enzyme-linked<br />

16.<br />

Antitijela na ekstraktibilne<br />

nuklearne antigene - (ENA),<br />

imunoblot<br />

MP-5.5-051-26/1<br />

Imunoblot<br />

Imunoblot<br />

Klinička kemija/Clinical Chemistry<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

Apolipoprotein A-I<br />

Apolipoprotein A-I<br />

MP-5.5-052-2/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

2.<br />

Apolipoprotein B<br />

Apolipoprotein B<br />

MP-5.5-052-3/1<br />

3.<br />

Žučne kiseline<br />

Total bile acids<br />

MP-5.5-052-5/1<br />

Enzimatska kolorimetrijska<br />

Enzymatic<br />

spectrophotometry<br />

4.<br />

5.<br />

Mioglobin<br />

Myoglobin<br />

NT-proBNP<br />

N-terminal pro B-type<br />

natriuretic peptide<br />

MP-5.5-052-6/1<br />

MP-5.5-052-8/1<br />

Elektrokemiluminiscentna<br />

imunoanaliza<br />

Electrochemiluminescece<br />

immunoassay<br />

Serum, plazma<br />

Serum, plasma<br />

6.<br />

Eritropoietin<br />

Erythropoietin<br />

MP-5.5-052-9/1<br />

Enzimimuno analiza<br />

(ELISA)<br />

Enzyme-linked<br />

7.<br />

Vitamin B12<br />

Vitamin B12<br />

MP-5.5-052-10/1<br />

Elektrokemiluminiscentna<br />

imunoanaliza<br />

Electrochemiluminescece<br />

immunoassay<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 13 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

8.<br />

Folna kiselina<br />

Folic acid<br />

MP-5.5-052-11/1<br />

9.<br />

10.<br />

Vitamin D<br />

Vitamin D total (25-<br />

Hydroxyvitamin D)<br />

Osteokalcin<br />

Osteocalcin<br />

MP-5.5-052-12/1<br />

MP-5.5-052-13/1<br />

Elektrokemiluminiscentna<br />

imunoanaliza<br />

Electrochemiluminescece<br />

immunoassay<br />

Serum, plazma<br />

Serum, plasma<br />

11.<br />

Beta-CrossLaps<br />

Beta-CrossLaps<br />

MP-5.5-052-14/1<br />

12.<br />

13.<br />

Kristali mokraćne kiseline<br />

Uric acid crystals in sinovial<br />

fluid<br />

Kristali pirofosfata<br />

Pyrophosphate crystals in<br />

syinovial fluid<br />

MP-5.5-052-17/1<br />

MP-5.5-052-18/1<br />

Mikroskopski pregled<br />

Bright field microscopy<br />

Zglobna tekućina<br />

Synovial fluid<br />

14.<br />

Hemoglobin, slobodni<br />

Haemoglobin free<br />

MP-5.5-052-21/1<br />

Spektrofotometrijska<br />

Spectrophotometry<br />

15.<br />

Elektroforeza serumskih<br />

proteina<br />

Electrophoresis of serum<br />

MP-5.5-052-22/1<br />

Elektroforeza<br />

Electrophoresis<br />

Serum<br />

Serum<br />

16.<br />

Imunofiksacija u serumu<br />

Immunofixation of serum<br />

MP-5.5-052-24/1<br />

Imunofiksacija<br />

Immunofixation<br />

17.<br />

Imunoglobulin G (IgG)<br />

Immunoglobulin G (IgG)<br />

MP-5.5-052-25/1<br />

18.<br />

Imunoglobulin A (IgA)<br />

Immunoglobulin A (IgA)<br />

MP-5.5-052-26/1<br />

Imunoturbidimetrija<br />

Immunoturbidimetry<br />

19.<br />

Imunoglobulin M (IgM) u<br />

serumu i plazmi<br />

Immunoglobulin M (IgM) in<br />

MP-5.5-052-27/1<br />

Serum, plazma<br />

Serum, plasma<br />

20.<br />

Imunoglobulin G (IgG)<br />

Immunoglobulin G (IgG)<br />

MP-5.5-052-28/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

21.<br />

Imunoglobulin A (IgA)<br />

Immunoglobulin A (IgA)<br />

MP-5.5-052-29/1<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 14 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

22.<br />

Imunoglobulin M (IgM)<br />

Immunoglobulin M (IgM)<br />

MP-5.5-052-30/1<br />

Serum, plazma<br />

Serum, plasma<br />

23.<br />

24.<br />

Ig/L-kapa, lagani lanci<br />

imunoglobulina kapa tipa<br />

Ig/L-kappa, immunoglobulin<br />

Ig/L-lambda, lagani lanci<br />

imunoglobulina lambda tipa<br />

Ig/L-lambda, immunoglobulin<br />

MP-5.5-052-31/1<br />

MP-5.5-052-32/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

Serum<br />

Serum<br />

25.<br />

26.<br />

Imunofiksacija u mokraći<br />

Immunofixation in urine<br />

U – Slobodni laki lanci Ig u<br />

mokraći, kvalitativno<br />

Free light chains in urine,<br />

MP-5.5-052-35/1<br />

MP-5.5-052-36/1<br />

Imunofiksacija<br />

Immunofixation<br />

24-satna mokraća<br />

24h urine<br />

27.<br />

Ceruloplazmin<br />

Ceruloplasmin<br />

MP-5.5-052-37/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

28.<br />

Haptoglobin<br />

Haptoglobin<br />

MP-5.5-052-38/1<br />

29.<br />

Transferin<br />

Transferrin<br />

MP-5.5-052-39/1<br />

30.<br />

Alfa-1-antitripsin<br />

Alpha1-antitrypsin<br />

MP-5.5-052-40/1<br />

Imunoturbidimetrija<br />

Immunoturbidimetry<br />

Serum, plazma<br />

Serum, plasma<br />

31.<br />

beta – 2 – mikroglobulin<br />

beta – 2 – microglobulin<br />

MP-5.5-052-41/1<br />

32.<br />

C3 komponenta komplementa<br />

C3 component of complement<br />

MP-5.5-052-42/1<br />

33.<br />

C4 komponenta komplementa<br />

C4 component of complement<br />

MP-5.5-052-43/1<br />

34.<br />

Albumin<br />

Albumin<br />

MP-5.5-052-45/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

Porcija mokraće,<br />

24-satna mokraća<br />

Urine, random<br />

sample and 24h<br />

35.<br />

Albumin/kreatinin<br />

Albumin/creatinine<br />

MP-5.5-052-46/1<br />

Računski parametar<br />

Calculated parameter<br />

Mokraća<br />

Urine<br />

36.<br />

alfa-1- mikroglobulin<br />

Alpha-1-microglobulin<br />

MP-5.5-052-47/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

37.<br />

Alfa-1-antitripsin –<br />

fenotipizacija<br />

Alpha-1 antitrypsin,<br />

phenotyping<br />

MP-5.5-052-49/1<br />

Izoelektrično fokusiranje i<br />

imunofiksacija<br />

Isoelectric focusing &<br />

immunofixation<br />

Serum, plazma<br />

Serum, plasma<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 15 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

38.<br />

Dokazivanje očuvanosti barijere<br />

i intratekalne sinteze IgG u SŽS<br />

Blood-cerebrospinal fluid<br />

MP-5.5-052-50/1<br />

Računski parametar<br />

Calculated parameter<br />

39.<br />

40.<br />

Albumin barijera<br />

Albumin barrier<br />

Imunoglobulin G, barijera<br />

Immunoglobulin G, barrier<br />

MP-5.5-052-51/1<br />

MP-5.5-052-52/1<br />

Imunonefelometrija<br />

Immunonephelometry<br />

Likvor i serum<br />

CSF and serum<br />

41.<br />

Dokazivanje oligoklonskih<br />

IgG(tip 1-5)-Sebia<br />

Oligoclonal IgG bands (OCB)<br />

MP-5.5-052-53/1<br />

Izoelektrično fokusiranje i<br />

imunofiksacija<br />

Isoelectric focusing &<br />

immunofixation<br />

Klinička jedinica za molekularnu dijagnostiku<br />

Molekularna dijagnostika/Molecular Diagnostics<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

1.<br />

2.<br />

3.<br />

4.<br />

5.<br />

6.<br />

7.<br />

8.<br />

CYP2C9 (*2,*3), genotipizacija<br />

citokroma P-450<br />

CYP2C9 - genotyping of alelles<br />

CYP2C19 (*2,*3),<br />

genotipizacija citokroma P-450<br />

CYP2C19 - genotyping of<br />

VKORC1 (C1173T, G1639A)<br />

genotipizacija gena podjedinice<br />

1 K-vitamin reduktaze<br />

5-HTTLPR L/S polimorfizam<br />

(genotipizacija serotoninskog<br />

transportera)<br />

5-HTTLPR L/S polimorphysm<br />

(serotonin transporter<br />

ACE (ID polimorfizam),<br />

genotipizacija angiotenzin<br />

konvertaze<br />

Angiotensine converting enzime<br />

(ACE) - genotyping of I/D<br />

UGT1A1 (TA6/7)<br />

genotipizacija UDP-glukuroniltransferaze<br />

(Gilbertov sindrom)<br />

UDP glucuronyl transferase<br />

( G 1A1 G lb d )<br />

HFE (H63D, S65C, C282Y),<br />

genotipizacija nasljedne<br />

hemokromatoze<br />

Alfa-1-antitripsin (AAT) –<br />

genotipizacija alela PiZ<br />

(Glu342Lys) i PiS (Glu264Val)<br />

MP-5.5-060-1/1<br />

MP-5.5-060-2/1<br />

MP-5.5-060-3/1<br />

MP-5.5-060-4/1<br />

MP-5.5-060-11/1<br />

MP-5.5-060-12/1<br />

MP-5.5-060-21/1<br />

MP-5.5-060-22/1<br />

Analiza krivulje taljenja<br />

Melting curve analysis<br />

Lančana reakcija<br />

polimeraze (PCR)<br />

Polimerase chain<br />

reaction (PCR)<br />

Analiza krivulje taljenja<br />

Melting curve analysis<br />

DNA<br />

DNA<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 16 od/of 17


Prilog potvrdi o akreditaciji<br />

Annex to the Accreditation Certificate<br />

7132<br />

Datum izdanja priloga/ Annex Issued on 2012-12-28<br />

Zamjenjuje prilog od/Replaces Annex dated:<br />

br.<br />

Pretraga<br />

Examination<br />

Postupak/izdanje<br />

Procedure/revision<br />

Vrsta ispitivanja<br />

Type of examination<br />

Uzorak<br />

Sample<br />

9.<br />

Faktor koagulacije V -<br />

genotipizacija mutacije G1691A<br />

(Leiden) (LightCycler)<br />

MP-5.5-060-31/1<br />

10.<br />

Faktor koagulacije II<br />

(protrombin) - genotipizacija<br />

mutacije G20210A<br />

MP-5.5-060-32/1<br />

11.<br />

Apolipoprotein E (Apo E) –<br />

genotipizacija alela E2, E3 i E4<br />

(LightCycler)<br />

MP-5.5-060-33/1<br />

Analiza krivulje taljenja<br />

Melting curve analysis<br />

DNA<br />

DNA<br />

12.<br />

Inhibitor aktivatora<br />

plazminogena-1 (PAI-1) -<br />

genotipizacija polimorfizma<br />

MP-5.5-060-34/1<br />

13.<br />

Metilentetrahidrofolat reduktaza<br />

(MTHFR) - genotipizacija<br />

polimorfizma C677T<br />

MP-5.5-060-35/1<br />

HAA-Ob-7/7-2/8 /Izdanje/Issue:3 stranica/page 17 od/of 17

More magazines by this user
Similar magazines